Rapt Therapeutics Inc.
13F holders, Q2 2025 (June 30)2holders −90
0new positions
90sold out
$8.00avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Rapt Therapeutics Inc. in their 13F filings, down 90 from Q1 2025. 0 opened new positions and 90 sold out. The largest holders were Column Group LLC ($10.6M) and AJU IB Investment Co., Ltd. ($99K).
- Company
- Rapt Therapeutics Inc.
- CUSIP
- 75382E109
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 90 | $158.2M |
All 13F filers, Q1 2025 → Q2 2025: 129,768,681 shares sold, net −129,768,681 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Column Group LLC | 16.17% | No change | 1,328,613 | $10.6M |
| AJU IB Investment Co., Ltd. | 0.11% | Reduce -87.5% | 12,437 | $99K |
"% of holder's portfolio" is RAPT THERAPEUTICS INC's weight in each manager's 13F, not the share of Rapt Therapeutics Inc. the manager owns.